STAT+: AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality
Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an…
Category: stat-breakthrough-summit
Black women founders offer health tech solutions to combat Black maternal mortality
When Black people receive maternal care, they are often not treated the same as white…
STAT+: ChatGPT for genomes: introducing a CRISPR-designing generative AI
In 2018, during her chemistry Nobel Prize lecture, Frances Arnold noted that scientists had arrived…
STAT+: Venture capitalist Bob Kocher on generative AI startups, Change Healthcare cyberattack
SAN FRANCISCO — Health tech investor Bob Kocher has seen some bad AI-related startup pitches…
STAT+: Wearable devices generate powerful data but it’s not useful to doctors, yet
Just because the Food and Drug Administration has given the Apple Watch and other wearable…
STAT+: Amid acquisition speculation, Cytokinetics CEO stresses company can launch heart drug on its own
As Cytokinetics faces pressure to sell itself to a large pharma company following positive late-stage…
STAT+: Data integrity watchdogs call for stronger safeguards in scientific journals
SAN FRANCISCO — According to Elisabeth Bik, a scientific watchdog who has discovered thousands of…
Listen: Live! From the STAT Breakthrough Summit West
On this week’s “Readout LOUD,” we’re live in San Francisco at STAT’s Breakthrough Summit West….
Amid backlash to harm reduction, addiction experts warn against reprising ‘war on drugs’
SAN FRANCISCO — Amid what feels like an ever-worsening drug crisis here, locals and politicians…
STAT+: NVIDIA’s Kimberly Powell touts progress on AI in drug discovery
SAN FRANCISCO — In the world of drug discovery, AI progress is often measured by…
STAT+: Microsoft’s Peter Lee says ChatGPT shouldn’t be used for initial diagnosis
SAN FRANCISCO — Surging interest in generative AI among medical professionals since ChatGPT’s launch is…
STAT+: Analysis of pharmaceutical R&D ranks Novo Nordisk and Johnson & Johnson above their peers
When it comes to bringing an experimental drug to market and selling it, Novo Nordisk,…
STAT+: Patient advocates clash over wisdom of ‘approving drugs faster and faster’
NEW YORK — Over 30 years ago, Gregg Gonsalves and other AIDS activists persuaded Congress…
STAT+: How biotech investors spot opportunity when stocks are down — and up
Following a blockbuster year of dealmaking and a recent uptick in biotech stocks, top investors…
STAT+: Drug development was once a marathon. New tools and timelines are turning it into a sprint
Drug development is more of a sprint than a marathon these days, thanks to more…
Male birth control research wins audience over at STAT Madness event
What happens when too many excellent, pioneering researchers enter a room? A little madness. That’s…
Listen: Live! From the STAT Breakthrough Summit East
Is there a cure for allergies? Has the FDA become too flexible? And which drugs…
Top U.S. addiction researcher calls GLP-1 data for addiction ‘very, very exciting’
Early data regarding the use of GLP-1 medications like Ozempic and Wegovy to treat addiction…
STAT+: Ibogaine, the psychedelic, unlikely to receive approval as opioid treatment, says top addiction researcher
The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction,…
STAT+: Regeneron’s plot to ‘cure’ allergies
George Yancopoulos is in touch with his teenage self. After 35 years as head scientist…
Getting CRISPR treatments to patients remains a major challenge. Could lab-developed tests help?
CRISPR is no longer a promising but unproven technology — it is a reality. But…
STAT+: Feng Zhang suggests Editas didn’t move quickly enough to find product targets
When the first biotech companies emerged to capitalize on the revolutionary genome-editing technology CRISPR, Editas…
Extending the reach of gene therapies means hurdling not just scientific barriers but prices, too
While Covid-19 struck a blow to a vast number of clinical trials around the world,…
The world will not exit Covid-19 pandemic without booster shots, vaccine developer says
The world will not get the Covid-19 pandemic under control without using booster shots for…